Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 ...